Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leila Maghsoumi-Norouzabad has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmad Zare Javid

    Nutrition and Metabolic Diseases Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    5 shared publications
  • Ahmad Zare Javid

    Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    4 shared publications
  • Leila Hosseini

    Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

    3 shared publications
  • Ali Tarighat-Esfanjani

    Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

    2 shared publications
  • Alireza Bagherzadeh-Karimi

    Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran

    2 shared publications
  • Hadi Bazyar

    Student Research Committee, Sirjan School of Medical Sciences, Sirjan, Iran

    2 shared publications

Latest Publications

  • Open Access

    Investigating the effect of intermittent fasting (time-restricted eating) with and without calorie restriction compared to calorie restriction on anthropometric parameters, depression score, and metabolic factors in patients with major depression disorder and obesity: a study protocol for a randomized controlled trial

    by Alireza Bagherzadeh-Karimi, Naimeh Mesri Alamdari, Leila Hosseini, Leila Maghsoumi-Norouzabad

    It is suggested that intermittent fasting, specifically time-restricted eating (TRE), may have potential impact on depression in obese patients with major depression disorder (MDD). This study will aim to evaluate the effects of TRE with and without calorie restriction, compared to the traditional calorie restriction in patients suffering from MDD and obesity. This single-center, single-blinded, prospective, randomized trial will be conducted on 90 obese patients with major depression over 24 weeks. Participants were randomly divided into three groups in a 1:1:1 ratio. Group 1: recipients of TRE with 8-h food intake restriction (fixed 8-h time period), 2: recipients of TRE (fixed 8-h time period) and calorie restriction (75% of required calories), and 3: group receiving calorie restriction (75% of required calories). The primary objective is assessment of changes in depression severity scores, alongside secondary outcomes including changes in parameters such as body weight, body mass index (BMI), waist circumference, fat mass, fat-free mass, circadian rhythm score, quality of life, physical activity, and key metabolic factors such as fasting glucose levels, serum insulin, hemoglobin A1C, insulin resistance and sensitivity, lipid profile, and blood pressure. While calorie restriction can promote weight loss, its long-term adherence and mental health effects remain inconsistent. Emerging approaches like TRE have shown promise in improving body weight and metabolic parameters, but their impact on mental health is less understood. This study aims to fill this gap by comparing time-restricted eating with a fixed 8-h eating window plus and minus calorie restriction, against standard calorie restriction, in obese patients with major depressive disorder. The findings could have significant clinical implications for integrated management of obesity and depression. Iran Clinical Trials Registry, IRCTID: (https://irct.behdasht.gov.ir/IRCT20241029063543N1). Registered on 26-11-2024.


  • Neuroprotective mechanisms of sodium butyrate in Parkinson’s disease in preclinical rodent models: a systematic review and meta-analysis

    by Leila Hosseini, Azizeh Farshbaf-Khalili, Arezoo Moini Jazani, Leila Maghsoumi-Norouzabad

    In this study, we performed a systematic review and meta-analysis to assess existing preclinical evidence and potential sodium butyrate (NaB) mechanisms, specifically focusing on motor function, neuroinflammation, and dopaminergic markers in PD animal models. PubMed, Embase, Scopus, and Web of Science were searched until October 2024. Universal desktop ruler software was used to extract numerical values and the data was analyzed with RevMan 5.3. The SYRCLE risk of bias tool and CAMARADES checklist were used to assess quality assessment and the risk of bias in animal studies. The results of the included studies indicate that NaB administration was associated with improvements in motor function and exploratory behavior, as evidenced by performance on the rotarod, pole, open field, and narrow beam walk tests. Regarding neurochemical and histological markers, this meta-analysis revealed no statistically significant overall effect of NaB on tyrosine hydroxylase–positive (TH +) neuron counts in the substantia nigra pars compacta (SNpc). However, subgroup analyses identified specific conditions under which significant effects emerged: higher dosages (> 300 mg/kg) combined with prolonged treatment duration were associated with a significant increase in TH + neurons in the SNpc. Similarly, while the overall effect on striatal TH expression was significant, this effect was primarily driven by studies using lower dosages (< 300 mg/kg) administered over a long duration. For neuroinflammatory markers, NaB administration was associated with a significant overall reduction in brain levels of tumor necrosis factor-alpha (TNF-α), an effect consistent across various dosages and durations. Brain levels of interleukin-6 (IL-6) also showed a significant overall decrease, with subgroup analyses indicating this effect was most pronounced with lower dosages (< 300 mg/kg) and long-term administration. In contrast, NaB showed no significant overall effect on brain interleukin-1 beta (IL-1β), serum levels of TNF-α or IL-6, or markers of glial activation (allograft inflammatory factor 1 (IBA1), and glial fibrillary acidic protein). Notably, while the overall effect on IBA1 was non-significant, subgroup analysis suggested a potential reduction with lower dosages and short-term treatment. No significant effects were observed for brain-derived neurotrophic factor (BDNF), dopamine, serotonin, or their metabolites (3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid). The findings indicate that NaB improve behavioral functions in experimental models of PD and warrant further investigation as a potential therapeutic strategy.


  • Open Access

    The Effects of Prebiotic Dietary Fibers, Probiotics, and Synbiotics on Gut Permeability and Immunity: A Systematic Review

    by Leila Maghsoumi-Norouzabad, Alireza Bagherzadeh-Karimi, Shabnam Aliakbari Majd, Leila Hosseini, Fatemeh Shahi

    Modulation of intestinal barrier, which function through zonulin pathway downregulation, represents a promising therapeutic strategy for chronic diseases. This systematic review aimed to evaluate the effects of prebiotic dietary fibers, probiotics, and synbiotics on intestinal permeability and immunity. A systematic literature search of the EMBASE, PubMed, Web of Science, and Scopus electronic databases was conducted from database inception up to May 2024, supplemented by manual reference list searches. Included studies met the following criteria: (a) English language publications; (b) clinical trials; (c) investigated each factor of serum or fecal zonulin levels, serum or fecal calprotectin, glucagon-likepeptide-2 (GLP-2), short chain fatty acids (SCFAs), long chain fatty acids (LCFAs), fecal bile acid (BA), LPS-binding protein (LBP), lipopolysaccharide (LPS), intestinal microbiota composition, or inflammatory factors such as interleukin 6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP); (d) supplemented prebiotic dietary fibers, probiotics, or symbiotics. Studies were excluded if they contained insufficient data or involved supplementation alongside other interventions. The study quality and risk of bias were assessed using Jadad’s Score. A total of 36 studies were included in this review. Of these, 14 articles (n=580 participants) evaluated the effect of dietary prebiotics, 18 articles (n=1502 participants) evaluated the effect of probiotics, and six articles (n=517 participants) examined the effect of synbiotics on intestinal health and immunity markers. According to the evidence presented in this study, prebiotic whole foods or food enriched with prebiotics, probiotics, and synbiotics might have favorable effects on the serum levels of zonulin as a measure of intestinal permeability. The effects on GLP-2, gut microbiota, and their metabolites (e.g., LCFAs/SCFAs and BA) were contradictory and inconclusive. Some studies indicated increased levels of Bifidobacteria and SCFA with prebiotic supplementation or prebiotics-enriched food products. Fecal calprotectin (as an important marker of the local gut inflammation), tumor necrosis factor-α (TNF-α), and hs-CRP were unaffected in most studies. The lack of consistent replication across studies made it difficult to draw definitive conclusions about the effects of prebiotics, probiotics, and synbiotics on gut-related health and immunity. Therefore, further evidence is required before definitive recommendations can be established.


  • Open Access

    The effect of Fenugreek seed dry extract supplement on glycemic indices, lipid profile, and prooxidant-antioxidant balance in patients with type 2 diabetes: A double-blind randomized clinical trial

    by Fatemeh Chehregosha, Leila Maghsoumi-Norouzabad, Majid Mobasseri, Laleh Fakhr, Ali Tarighat-Esfanjani

    Introduction: This study aims to determine the effects of fenugreek seed dry extract (FDE) on the glycemic indices, lipid profile, and prooxidant-antioxidant balance (PAB) in patients with type 2 diabetes (T2D). Methods: A double-blind randomized clinical trial was carried out on 54 individuals with T2D. Participants were randomly assigned to a FDE group (received 3 tablets containing 335 mg of FDE daily for 8 weeks) or a placebo group (received tablets containing microcrystalline cellulose). Anthropometric indices, physical activity, diet, fasting blood sugar (FBS), serum insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), triglyceride (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein (HDL-C), and PAB were assessed. Results: An eight-week intake of 3 tablets containing 335 mg of FDE decreased serum insulin (P=0.016, P<0.001), HOMA-IR (P=0.009, P<0.001), TG (P<0.001, P=0.001), and PAB (P<0.001, P<0.001) compared to the baseline, in both placebo and intervention groups respectively. TC decreased significantly compared to the baseline in the placebo group (P=0.028), while HDL-C increased in the FDE group compared to the baseline (P<0.001) and placebo group (P=0.014). Conclusion: In the present study even though changes of parameters were more in intervention group compared to the control group, we did not observe any significant differences between studied groups except for HDL-C. However, the effects might become apparent with a higher dosage, longer study duration, or a larger sample size compared to the placebo group. Further clinical trials are needed in this regard.


  • Open Access

    Beneficial effects of cranberry juice enriched with omega-3 fatty acids in patients with type 2 diabetic and periodontal disease: A randomized pilot clinical trial

    by Elnaz Ashrafzadeh, Hossein Babaei, Maryam Ravanbakhsh, Ahmad Zare Javid, Leila Maghsoumi-Norouzabad

    Background. The present study evaluated the effects of cranberry juice enriched with omega-3 on inflammatory, oxidative stress, and periodontal status in diabetic patients with periodontal disease. Methods. Forty-one patients with diabetes (35‒67 years old) and periodontal disease were assigned to four groups: C: control (n=12), I1: omega-3 (n=10, 1 g), I2: cranberry juice (n=9, 200 mL), and I3: cranberry juice enriched with omega-3 (n=10, 200 mL, containing 1 g of omega-3) twice daily for 8 weeks. Serum and salivary total antioxidant capacity (TAC), malondialdehyde (MDA), serum uric acid, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), clinical attachment loss (CAL), pocket depth (PD), bleeding on probing (BOP), and plaque index were evaluated in all the subjects before and after the intervention. Results. Serum and salivary TAC increased, and salivary MDA decreased in the I3 group compared with the control group. Additionally, serum MDA decreased in the I2 and I3 groups while serum TAC increased. Serum hs-CRP, IL-6, and TNF-α decreased in the I3 group compared with the baseline. Furthermore, serum hs-CRP and IL-6 decreased in the I3 group compared with the control group. After the intervention, PD and CAL significantly reduced in all the groups. Conclusion. The consumption of cranberry juice enriched with omega-3 can be helpful as adjuvant therapy with non-surgical periodontal treatment in decreasing serum levels of IL-6 and hs-CRP, as well as serum and salivary levels of MDA while also increasing serum and salivary levels of TAC.


  • Open Access

    The association of vitamin D, semen parameters, and reproductive hormones with male infertility: A cross-sectional study

    by Leila Maghsoumi-Norouzabad, Maryam Labibzadeh, Ahmad Zare Javid, Seyed Ahmad Hosseini, Gholam Abbas Kaydani, Maryam Dastoorpur

    Background: The prevalence of vitamin D deficiency and male infertility is high in Iran. Objective: The present research aimed to examine the association between serum vitamin D [25(OH)D], parameters of semen including semen volume, sperm count, motility and morphology, and reproductive hormones in infertile Iranian men. Materials and Methods: This was a cross-sectional study on 119 infertile men conducted between September 2018 and May 2019. Subjects were divided into 3 groups based on serum vitamin D levels: deficient (< 10 ng/mL), insufficient (10 ng/mL ≤ 25(OH)D ≤ 30 ng/mL), and sufficient (> 30 ng/mL). Body mass index and waist circumference were measured. 25(OH)D, testosterone, sex hormone-binding globulin, luteinizing hormone (LH), follicle-stimulating hormone and estradiol levels, and semen parameters were assessed. Results: The semen volume, sperm counts, total and progressively motile sperm, normal sperm morphology, testosterone levels, and testosterone/estradiol ratio were substantially higher in the sufficient group compared to the other groups (p < 0.001). Also, in the sufficient group, serum LH (p < 0.001) and estradiol (p < 0.001, p = 0.01) were notably lower and serum sex hormone-binding globulin (p < 0.001) and the testosterone/LH ratio (p < 0.001) were considerably higher compared to the insufficient and deficient groups. Conclusion: Our study showed a positive relationship between serum vitamin D levels, and seminal parameters and sex hormones in Iranian infertile males. Key words: Infertility, Male, Vitamin D, Semen analysis, Gonadal hormones, Pituitary hormones.


  • Open Access

    Effects of Concurrent Omega-3 and Cranberry Juice Consumption Along with Standard Antibiotic Therapy on the Eradication of Helicobacter pylori, Gastrointestinal Symptoms, Some Serum Inflammatory and Oxidative Stress Markers in Adults with Helicobacter pylori Infection: A Study Protocol for a Randomized Controlled Trial

    by Ahmad Zare Javid, Leila Maghsoumi-Norouzabad, Hadi Bazyar, Vahideh Aghamohammadi, Pejman Alavinejad

    Background: It seems alternative treatments such as antioxidant intervention and anti-inflammatory intervention adjuvant to antibiotic regimens may enhance cancer prevention approaches and decrease adverse side effects related to therapeutic antibiotic regimens. So, we will evaluate the effects of concurrent omega-3 and cranberry juice supplementation along with standard antibiotic therapy on the eradication of Helicobacter pylori, gastrointestinal symptoms, some serum inflammatory and oxidative stress markers in adults with HP infection. Methods: We will conduct a 4-week double-blinded randomized clinical trial. The subjects will be randomly stratified according to sex and BMI using a permuted block randomization procedure by Random Allocation Software (RAS). They will be assigned to one of the four study groups: (1) cranberry juice fortified with omega-3 Intervention (n=23), (2) cranberry juice intervention group (n=23), (3) placebo beverage fortified with omega-3 intervention group (n=23), and (4) placebo beverage intervention (control group) (n=23). All statistical analyses will be performed using IBM SPSS Statistics software. Discussion: A combination of alternative therapies may have a synergistic effect compared to a single approach. It could potentially be more effective in promoting the efficacy of standard antibiotic therapy in eradicating HP infection. Trial Registration: Iranian Registry of Clinical Trials (IRCT20151128025274N3, www.irct.ir/trial/28997). Trial Status: This study is in the early stages of sampling.


  • Open Access

    The Impact of Obesity on Various Semen Parameters and Sex Hormones in Iranian Men with Infertility: A Cross-Sectional Study

    by Leila Maghsoumi-Norouzabad, Ahmad Zare Javid, Saleh Aiiashi, Seyed Ahmad Hosseini, Mohammadreza Dadfar, Hadi Bazyar, Maryam Dastoorpur

    Objective: The aim of this study was to examine the correlations between body mass index (BMI) and waist circumference (WC) and semen parameters (semen volume, sperm count, motility, and morphology) and sex hormones in Iranian men with infertility. Materials and Methods: In this cross-sectional study, a total of 119 male patients who had lived as a partner in an infertile couple for at least 1 year, after regular unprotected sexual intercourse in their married life were investigated. BMI and WC were assessed, and a morning blood sample was taken assessing serum levels of testosterone (T), sex hormone-binding globulin (SHBG), prolactin (PRL), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and leptin. Semen-analysis parameters were also measured. Results: Based on BMI and WC, the sperm count, total motility and progressive sperm were significantly lower in overweight and obese infertile males compared to that in normal weight infertile males and those with WC< 102 cm. In addition, the fraction of sperm with abnormal morphology was significantly higher in infertile men with WC> 102 cm compared to that in those with WC< 102 cm. Moreover serum levels of LH, FSH, and leptin were significantly higher in overweight and obese infertile males compared to that in normal weight infertile males and those with WC< 102 cm. Moreover serum level of E2 was significantly higher in obese infertile males compared to the normal weight infertile males and in those with WC> 102 cm compared to the WC< 102 cm. Furthermore, serum level of T was significantly lower in obese infertile males compared to the overweight infertile males and in those with WC> 102 cm compared to the WC< 102 cm. The mean of T/E2 ratio also was significantly lower in obese infertile males vs overweight and normal weight infertile males and in those with WC> 102 cm compared to the WC< 102 cm. Conclusion: We concluded that overweight and obesity in infertile men compared to those with normal weight may worsen the infertility situation.


  • Male adiposity, sperm parameters and reproductive hormones: An updated systematic review and collaborative meta‐analysis

    by Albert Salas‐Huetos, Leila Maghsoumi‐Norouzabad, Emma R. James, Douglas T. Carrell, Kenneth I. Aston, Timothy G. Jenkins, Nerea Becerra‐Tomás, Ahmad Zare Javid, Reza Abed, Pedro Javier Torres, et al.

    Summary: The present updated systematic review and meta‐analysis aims to summarize the evidence from published studies with low risk for any important bias (based on methodological quality assessment) investigating the potential associations of adiposity with sperm quality and reproductive hormones. We conducted a systematic search of the literature published in MEDLINE‐PubMed and EMBASE through June 2019. Based on the criteria in our review, 169 eligible publications were used for data abstraction. Finally, 60 articles were included in the qualitative analysis and 28 in the quantitative analysis. Our systematic review results indicated that overweight and/or obesity were associated with low semen quality parameters (i.e., semen volume, sperm count and concentration, sperm vitality and normal morphology) and some specific reproductive hormones (e.g., inhibin B, total testosterone and sex hormone‐binding globulin). Overweight and/or obesity were also positively associated with high estradiol concentrations. Meta‐analysis indicated that overweight and/or obesity categories were associated with lower sperm quality (i.e., semen volume, sperm count and concentration, sperm vitality, total motility and normal morphology), and underweight category was likewise associated with low sperm normal morphology. In conclusion, our results suggest that maintaining a healthy body weight is important for increasing sperm quality parameters and potentially male fertility.


  • Open Access

    The Impacts of Synbiotic Supplementation on Periodontal Indices and Biomarkers of Oxidative Stress in Type 2 Diabetes Mellitus Patients with Chronic Periodontitis Under Non-Surgical Periodontal Therapy. A Double-Blind, Placebo-Controlled Trial

    by Hadi Bazyar, Leila Maghsoumi-Norouzabad, Mohsen Yarahmadi, Hassan Gholinezhad, Leila Moradi, Parvin Salehi, Mohammad Hosein Haghighi-Zadeh, Ahmad Zare Javid

    Aim: The aim of the current study was to investigate that combination of the synbiotic supplementation in adjunct with non-surgical periodontal therapy (NSPT) is useful in treating periodontitis and biomarkers of oxidative stress in type 2 diabetes mellitus (T2DM) patients. Methods: In this study, 47 patients suffering from DM and CP were recruited and randomly assigned to two groups. The intervention (n= 23) and control (n=24) groups received either multispecies probiotic supplement plus 100 mg fructo-oligosaccharide (500 mg in each capsule) or placebo capsule containing 500 mg wheat flour, respectively, every day for 8 weeks. All subjects were treated with NSPT during the intervention period. Serum levels of interleukin-1β (IL-1β), malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and periodontal indices including clinical attachment loss (CAL), pocket depth (PD) (main outcome), BOP, and plaque index were measured before and after the intervention. Results: Supplementation with the synbiotic with NSPT led to a significant decrease in the levels of IL-1β, MDA, plaque index, PD, and CAL in the intervention group post-intervention (p < 0.05). The serum levels of TAC, SOD, and GPx were significantly increased in the intervention group compared with the baseline (p < 0.05). Consumption of synbiotic with NSPT, compared to the control, resulted in a significant decrease in the mean changes of IL-1β, MDA, and CAL (p < 0.05). Also, the mean changes of TAC and GPx were significantly higher in the intervention group compared with the control group (p < 0.05). Also, in the intervention group was seen a significant reduction in plaque index (p = 0.035) and BOP (p = 0.04) compared with the control group. Conclusion: It was observed that synbiotic supplementation with NSPT may be beneficial in improving inflammatory, antioxidant, and periodontal status in T2DM patients with CP.